Replies to post #518269 on NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

Fact check …
Always consider the source. The Wizard of Oz might not be exactly as he appears if you look behind the curtain.

[biosectinvestor]

That is in the “risk factors” section and they also explained, as they did in their presentation how they dealt with it. The purpose of the Risk Factor sections of SEC filings is to warn investors of things that MIGHT happen, not what will happen. They cover all kinds of bad things and if floods or hurricanes were a big factor it would cover those too, to ensure that in any court, it could be said that the “investor had been warned” about potential risks and they knew and accepted those risks. This is not a bank CD.

We all know they have not received product marketing approval, which is different to saying that the change in the Statistical Analysis Plan was submitted and approved before they unblinded. Don’t
confuse naive READERS.

[Roman516]

Repeat and repeat, but the real fact of the matter is that NWBO succeeded
as the OS data results have already proven so thanks for pointing this out
again, and again. NWBO is on the right track.

[SkyLimit2022]

HyGro, I wonder why you don’t go over to the NVCR message board and post cherry-picked SEC disclosures from their February 24th 2022 SEC filing. Their risk disclosures start on page 26 of the NovoCure filing posted below. You stated that SEC filings are submitted under penalty of perjury and should be considered by investors. I tend to believe that the documents as a whole are important, but we could follow your lead and pluck out some interesting risk statements to publish in isolation. What do you think?

https://d18rn0p25nwr6d.cloudfront.net/CIK-0001645113/c5eca622-306f-417f-931b-c2ab018fa6b6.pdf#page25